Emergent BioSolutions (EBS) Current Deferred Revenue (2010 - 2026)
Emergent BioSolutions (EBS) posted Current Deferred Revenue of $20.9 million for Q2 2026, up 18.75% on a QoQ basis from $17.6 million in Q1 2026.
Powered by 
Analysis
Emergent BioSolutions (EBS) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Current Deferred Revenue for 15 years, with the latest figure at $20.9 million in Q2 2026.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $20.9 million in Q2 2026; TTM through Jun 2026 was $20.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $14.4 million, changed N/A from the prior year.
- Current Deferred Revenue was $20.9 million for Q2 2026 at Emergent BioSolutions, up from $17.6 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $20.9 million in Q2 2026, with the low at $14.4 million in Q4 2025.
- Average Current Deferred Revenue over 3 years is $17.2 million, with a median of $16.8 million recorded in 2022.
- The largest YoY upside for Current Deferred Revenue was 85.9% in 2022 against a maximum downside of 85.9% in 2022.
- Over 3 years, Current Deferred Revenue stood at $15.9 million in 2022, then declined by 9.43% to $14.4 million in 2025, then surged by 45.14% to $20.9 million in 2026.
- The last three Current Deferred Revenue figures came in at $20.9 million (Q2 2026), $17.6 million (Q1 2026), and $14.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.90 Mn |
| Mar 31, 2026 | 17.60 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Mar 31, 2022 | 15.90 Mn |
| Dec 31, 2021 | 16.40 Mn |
| Sep 30, 2021 | 82.10 Mn |
| Jun 30, 2021 | 103.40 Mn |
| Mar 31, 2021 | 112.80 Mn |
| Dec 31, 2020 | 100.10 Mn |
| Sep 30, 2020 | 79.90 Mn |
| Jun 30, 2020 | 118.00 Mn |
| Mar 31, 2020 | 89.40 Mn |
| Dec 31, 2019 | 88.90 Mn |
| Sep 30, 2019 | 89.60 Mn |
| Jun 30, 2019 | 89.50 Mn |
| Mar 31, 2019 | 75.20 Mn |
| Dec 31, 2018 | 73.10 Mn |
| Sep 30, 2018 | 76.13 Mn |
| Jun 30, 2018 | 73.01 Mn |
| Mar 31, 2018 | 66.33 Mn |
API Access
Emergent BioSolutions Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();